fashion -WSS

fashion

author：fashion 2025-10-02 04:07:32 - browse：36

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Life science postdocs should get big pay hike, NIH panel says

focus

WSS

Scrutiny of post

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Questions and answers about ramping up H5N1 bird flu vaccine

Fauci's latest grilling in Congress: 9 hours, behind closed doors

JPM pitch from hospitals? Revenue streams outside of patient care

Fauci's latest grilling in Congress: 9 hours, behind closed doors

knowledge

fashion

knowledge

Peter Hotez and the public health issue of online harassment

UnitedHealth argues against case alleging wrongful AI care denials

Anesthesiologist group: stop taking Ozempic before surgery

Physician assistants need a new name. Here's what it should be

Apple is now the first public company to be valued at $3 trillion

Medicare Advantage overpayments discussion gets experts fired up

Guidelines to prevent youth baseball injuries need more muscle

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Cancer drug shortages should be causing more outrage

Medicare Advantage coverage denials need scrutiny, senators say

knowledge

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Nonprofit, backed by Microsoft, to certify AI tools in health care

American taxpayers paid $1.8 trillion in health care costs in 2022

A preacher's new calling: Diversifying neuroscience research

Addressing health care workers' trauma can help fight burnout

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Wikipedia

hotspot

focus

entertainment